<!--https://www.openaustralia.org.au/senate/?id=2016-03-01.112.1-->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
 <head>
  <meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
  <title>
   Hepatitis C: 1 Mar 2016: Senate debates (OpenAustralia.org)
  </title>
  <meta content="Making parliament easy." name="description"/>
  <meta content="Parliament, government, House of Representatives, Senate, Senator, MP, Member of Parliament, MPs, Australia, Australian, Hepatitis C: 1 Mar 2016" name="keywords"/>
  <meta content="5FBaCDi8kCKdo4s64NEdB5EOJDNc310SwcLLYHmEbgg=" name="verify-v1"/>
  <meta content="width=device-width; initial-scale=1.0; maximum-scale=1.0" name="viewport">
   <link href="mailto:contact@openaustralia.org" rel="author" title="Send feedback"/>
   <link href="http://www.openaustralia.org.au/" rel="home" title="Home"/>
   <link href="/" rel="start" title="Home"/>
   <!-- skin: mobile -->
   <link href="/style/default/global_non_ns4_mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/print.css" media="print" rel="stylesheet" type="text/css"/>
   <script type="text/javascript">
    var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
   </script>
   <script type="text/javascript">
    var pageTracker = _gat._getTracker("UA-3107958-3");
pageTracker._initData();
pageTracker._trackPageview();
   </script>
  </meta>
 </head>
 <body>
  <div id="container">
   <a name="top">
   </a>
   <div id="banner">
    <div id="title">
     <h1>
      <a href="/" title="To the front page of the site">
       <img alt="OpenAustralia.org beta" height="32" src="/images/openaustraliaorgbeta.gif" width="262"/>
      </a>
     </h1>
    </div>
   </div>
   <!-- end #banner -->
   <div id="content">
    <div class="stripe-head-1">
     <div class="main">
      <h2>
       Senate debates
      </h2>
      <h3>
       Tuesday, 1 March 2016
      </h3>
      <h4>
       Motions
      </h4>
      <h5>
       Hepatitis C
      </h5>
      <p>
       3:57 pm
      </p>
      <a name="g112.2">
      </a>
      <p class="speaker">
       <a href="/senator/?m=100303" title="See more information about Dean Smith">
        <img alt="Photo of Dean Smith" class="portrait" src="/images/mps/10768.jpg"/>
        <strong>
         Dean Smith
        </strong>
       </a>
       <small>
        (Liberal Party) |
        <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansards,hansards80%20Date%3A1%2F3%2F2016;rec=0;resCount=Default" title="The source of this piece of text">
         Hansard source
        </a>
       </small>
       <p>
        I move:
       </p>
       <p class="italic">
        That the Senate—
       </p>
       <p class="italic">
        (a)   notes that:
       </p>
       <p class="italic">
        (i)   from 1 March 2016, Australians will have access to a new generation of medicines for the treatment of chronic hepatitis C infection in adults,
       </p>
       <p class="italic">
        (ii)   more than 230,000 Australians are currently living with hepatitis C, and each year about 700 deaths are attributable to chronic hepatitis C infection,
       </p>
       <p class="italic">
        (iii)   around 10,000 Australians are diagnosed with hepatitis C each year, and
       </p>
       <p class="italic">
        (iv)   less than two per cent of Australian patients currently seek treatment for the deadly and debilitating disease;
       </p>
       <p class="italic">
        (b)   recognises the Federal Government is investing more than $1 billion to make the new treatments available on the
        <a href="http://en.wikipedia.org/wiki/Pharmaceutical_Benefits_Scheme" rel="nofollow">
         Pharmaceutical Benefits Scheme
        </a>
        from 1 March 2016;
       </p>
       <p class="italic">
        (c)   acknowledges the breakthrough cures could all but eradicate hepatitis C within a generation; and
       </p>
       <p class="italic">
        (d)   commends the Government, the
        <a href="http://en.wikipedia.org/wiki/Department_of_Health" rel="nofollow">
         Department of Health
        </a>
        , the
        <a href="http://en.wikipedia.org/wiki/Pharmaceutical_Benefits_Advisory_Committee" rel="nofollow">
         Pharmaceutical Benefits Advisory Committee
        </a>
        , Hepatitis Australia, physicians, patients and all those who have worked tirelessly to ensure the broadest possible access to these new medicines.
       </p>
       <p>
        Question agreed to.
       </p>
       <br/>
       <br/>
       <br/>
       <br/>
       <div id="footer">
        <p>
         <a href="/?show_pc">
          View the PC OA website
         </a>
        </p>
       </div>
      </p>
     </div>
    </div>
   </div>
  </div>
 </body>
</html>
